Studies on the interactions between human serum albumin and imidazolium [trans-tetrachlorobis (imidazol) ruthenate(III)]

Journal of Inorganic Biochemistry

Volumn 73, Issue 3, 1999, Pages 123-128

  Trynda Lemiesz, Lilianna ^a   Keppler, Bernhard K ^b   Kozłowski, Henryk ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Circular dichroism; Fluorescence quenching; Heme binding; Human serum albumin; Ruthenium(III)

Indexed keywords

BILIRUBIN; HEME DERIVATIVE; HUMAN SERUM ALBUMIN; IMIDAZOLE DERIVATIVE; RUTHENIUM COMPLEX;

ANISOTROPY; ARTICLE; BINDING SITE; CIRCULAR DICHROISM; COMPLEX FORMATION; DRUG PROTEIN BINDING; FLUORESCENCE SPECTROSCOPY; PROTEIN STRUCTURE; ULTRAVIOLET SPECTROSCOPY;

BILIRUBIN; BINDING SITES; CIRCULAR DICHROISM; HEME; HUMANS; IMIDAZOLES; IMMUNOCHEMISTRY; ORGANOMETALLIC COMPOUNDS; PROTEIN BINDING; RUTHENIUM; SERUM ALBUMIN; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY; SPECTROPHOTOMETRY, ULTRAVIOLET; TRYPTOPHAN; WARFARIN;

EID: 0033103292     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00004-5     Document Type: Article

References (33)

1. M.J. Clarke, Progress in Clinical Biochemistry and Medicine, vol. 10, Springer, Berlin, 1989, p. 25.
2. B.K. Keppler, G. Lipponer, B. Stenzel, F. Kranz, in: B.K. Keppler (Ed.), Metal Complexes in Cancer Chemotherapy, VCH, Weinheim, p. 187.
3. B.K. Keppler, M. Hartmann, Met. Based Drugs 1 (1994) 145.
4. F. Kranz, N. Mulinacci, L. Messori, I. Bertini, B.K. Keppler, in: J. Anastassopoulou, Ph. Collery, J.C. Etienne, Th. Theophanides (Eds.), Metal Ions in Biology and Medicine, vol. 2, J. Libbey Eurotext, Paris, p. 69.
5. F. Kratz, B.K. Keppler, L. Messori, C. Smith, E.N. Baker, Met. Based Drugs 1 (1994) 169.
6. F. Kratz, M. Hartmann, B.K. Keppler, L. Messori, J. Biol. Chem. 269 (1994) 2581.
7. F. Kratz, L. Messori, J. Inorg. Biochem. 49 (1993) 79.
8. D.C. Carter, J.X. Ho, Adv. Protein Chem. 45 (1994) 153.
9. T. Peters Jr., Adv. Protein Chem. 37 (1985) 161.
10. X.M. He, D.C. Carter, Nature 358 (1992) 209.
11. O.J.M. Bos, J.P.M. Remijn, J.E. Fisher, J. Witing, L.H.M. Janssen, Biochem. Pharmacol. 37 (1988) 3905.
12. T.P. King, Arch. Biochem. Biophys. 159 (1973) 509.
13. F. Kratz, N. Mulinacci, L. Messori, I. Bertini, B.K. Keppler, Met. Ions Biol. Med. 2 (1992) 69.
14. G.H. Beaven, S.H. Chen, A. D'Albis, W.B. Gratzer, Eur. J. Biochem. 41 (1974) 539.
15. G. Blauer, D. Harmatz, J. Snir, Biochim. Biophys. Acta 279 (1972) 68.
16. B.K. Keppler, Prog. Clin. Biochem. Med. 10 (1989) 41.
17. L. Messori, L. Kratz, E. Allesio, Met. Based Drugs 3 (1996) 1.
18. S.F. Mason, Molecular Optical Activity and the Chiral Discrimination, Cambridge University Press, Cambridge, 1982.
19. N. Ohta, D. Chen, S. Ito, T. Futo, T. Yotsuyangi, K. Ikeda, Int. J. Pharm. 118 (1995) 85.
20. L. Trynda-Lemiesz, F. Pruchnik, J. Inorg. Biochem. 66 (1997) 187.
21. D. Freifelder, Physical Biochemistry: Applications to Biochemistry and Molecular Biology, W.H. Freeman, San Francisco, CA, 1976, p. 410.
22. T. Peters Jr., Clin. Chem. 23 (1977) 5.
23. Z. Hrkal, M. Kodiczek, Z. Vodrazka, B. Meloun, L. Moravek, Int. J. Biochem. 9 (1978) 349.
24. G. Blauer, D. Harmatz, A. Naparstek, FEBS Lett. (1970) 53.
25. L. Trynda, H. Przywarska-Boniecka, T. Koœciukiewicz, Inorg. Chim. Acta 135 (1987) 55.
26. O.J.M. Bos, J.P.M. Remijn, J.E. Fisher, J. Witing, L.H.M. Janssen, Biochem. Pharmacol. 37 (1988) 3905.
27. Y. Ozeki, Y. Kurono, T. Yotsuyangi, K. Ikeda, Chem. Pharm. Bull. 28 (1980) 535.
28. M. Otagiri, Y. Otagiri, J.H. Perrin, Int. J. Pharm. 2 (1979) 283.
29. S.F. Andres, M.Z. Atassi, Biochemistry 9 (1970) 2268.
30. S. Sakata, M.Z. Attasi, Mol. Immunol. 17 (1980) 139.
31. A.F.S.A. Habeeb, J. Immunol. 99 (1967) 1264.
32. L. Trynda, H. Przywarska-Boniecka, T. Koœciukiewicz, J. Inorg. Biochem. 38 (1990) 153.
33. I. Takahashi, T. Ohnuma, S. Kavy, S. Bhardwaj, J.F. Holland, Br. J. Cancer 41 (1980) 602.